Tazarotene
- Product NDC
- 51672-1374
- 11-digit product format
- 516721374
- Labeler code
- 51672
- Product ID
- 51672-1374_39620f25-787e-f51b-e063-6294a90a36de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tazarotene
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA208258
- Marketing category
- ANDA
- Marketing start
- 2017-04-03
- Substance
- TAZAROTENE
- Active strength
- 1 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tazarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAZAROTENE | 1 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 81BDR9Y8PS |
| Rxcui | 313200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-1374-2 | Tazarotene | 30 g in 1 TUBE | CREAM | 30 | | 6 |
| 51672-1374-2 | Tazarotene | 1 in 1 CARTON | CREAM | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-1374 | TAZAROTENE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20171029_34d79c31-1568-4797-a4f5-31200c7788db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-1374-2 | 51672137402 | 1 TUBE in 1 CARTON (51672-1374-2) / 30 g in 1 TUBE | 1 tube | 2017-04-03 | 0000-00-00 | No | No | Current |